2011

1. Watanabe, A. M. Tatematsu, K. Saeki, S. Shibata, H. Shime, A. Yoshimura, C. Obuse, T. Seya, and M. Matsumoto. 2011. Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation. J. Biol. Chem. 86:10702-10711.
2. Yabu, M., H. Shime, H. Hara, T. Saito, M. Matsumoto, T. Seya, T. Akazawa, and N. Inoue. 2011. IL-23-dependent and -independent enhancement pathway of IL-17A production by lactic acid. Int. Immunol. 23: 29-41.
3. Takaki, H., Y. Watanabe, M. Shingai, H. Oshiumi, M. Matsumoto, and T. Seya. 2011. Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential. Molec. Immunol. 48: 497-504.
4. Sawahata, R., H. Shime, S. Yamazaki, Y. Fujimoto, K. Fukase, T. Akazawa, N. Inoue, M. Matsumoto, and T. Seya. 2011. Failure of mycoplasmal lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2. Microbes Infect. 13:350-358.
5. Miyashita, M., H. Oshiumi, M. Matsumoto, and T. Seya. 2011. The SKI2-related helicase DDX60 is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Molec. Cell. Biol. 31: 3802-3819.
6. Ogawa, T., S. Tsuji-Kawahara, T. Yuasa, S. Kinoshita, T. Chikaishi, S. Takamura, H. Matsumura, T. Seya, T. Saga, and M. Miyazawa. 2011. Natural killer cells recognize Friend retrovirus infected erythroid progenitor cells through NKG2D-RAE-1 interactions in vivo. J. Virol. 85: 5423-5435.
7. Yamazaki, S., K. Okada, A. Maruyama, M. Matsumoto, and T. Seya. 2011. TLR2-dependent induction of IL-10 and Foxp3+CD25+CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo. PLoS ONE. 6 (4). e18833.
8. Aly, H. H., H. Oshiumi, M. Matsumoto, K. Shimotohno, T. Wakita, and T. Seya. 2011. Establishing mouse hepatoma cell lines permissive to human hepatitis C virus. PLoS ONE. 6 (6): e21284.
9. Wakasa, K., H. Shime, M. Kurita-Taniguchi, M. Matsumoto, M. Imamura, and T. Seya. 2011. Development of monoclonal antibodies that specifically interact with necrotic lymphoma cells. Microbiol. Immunol. 55: 373-377.
10. Seya, T. 2011. ADDENDUM to the paper published in MIMM by Takaki et al. Molec. Immunol. 48: 1589-1590.
11. Oshiumi, H., M. Okamoto, K. Fujii, T. Kawanishi, M. Matsumoto, S. Koike, and T. Seya. 2011. The TLR3-TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J. Immunol.187: 5320-5327.
12. Sancho-Shimizu, V., R. Perez de Diego, L. Lorenzo, R. Halwani, A. Alangari, S. Fabrega, A. Cardon, J. Maluenda, M. Tatematsu, F. Mahvelati, M. Herman, M. Ciancanelli, Y. Guo, A. Ghadiri, S. Boucheriti, S. Plancoulaine, C. Picard, F. Rosenberg, M. Tardieu, P. Lebon, E. Jouanguy, T. Seya, M. Matsumoto, N. Rezeai, D. Chaussabel, A. Puel, L. Abel, S-Y. Zhang, S. Al-Muhsen, and J-L. Casanova. 2011. Human TRIF deficiency in otherwise healthy patients with herpes simplex encephalitis. J. Clin. Invest.121: 4889-4902.
13. Itoh, H., A. Watanabe, K. Iwano, K. Funami, T. Seya, and M. Matsumoto. 2011. UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. PLoS ONE. 6(12): e28500.
14. Hazeki, K., Y. Kametani, H. Murakami, M. Uehara, K. Nigorokawa, S. Takasuga, T. Sasaki, M. Matsumoto, T. Seya, and O. Hazeki. 2012. Phosphoinositide 3-kinase controls the intracellular localization of CpG to limit DNA-PKcs-dependent IL-10 production in macrophages. PLoS ONE.6(10): e26836.
15. Matsumoto, M., H. Oshiumi, and T. Seya. 2011. Antiviral responses induced by the TLR3 pathway. Rev. Med. Virol. 21: 67-77 (review).
16. Seya T., J. Kasamatsu, M. Azuma, H. Shime, and M. Matsumoto. 2011. Natural killer cell activation secondary to innate pattern sensing. J. Innate Immunity. 3: 264-273.
17. Wakita, T., T. Suzuki, M. J. Evans, K. Shimotohno, K. Chayama, Y. Matsuura, M. Hijikata, K. Moriishi, T. Seya, N. Enomoto, K. Koike, N. Kato, T. Kanto, and H. Hotta. 2011. Will there be an HCV meeting in 2020: Summary of the 17th International Meeting on Hepatitis C Virus and Related Viruses. Gastroenterology 141: e1-5.